POLXF Stock - Polydex Pharmaceuticals Limited
Unlock GoAI Insights for POLXF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 |
|---|---|---|---|---|---|
| Revenue | $4.48M | $4.82M | $5.73M | $6.50M | $5.27M |
| Gross Profit | $-91,725 | $31,903 | $375,064 | $832,443 | $429,185 |
| Gross Margin | -2.0% | 0.7% | 6.5% | 12.8% | 8.2% |
| Operating Income | $-1,175,609 | $-2,056,381 | $-1,011,902 | $-801,568 | $-1,388,511 |
| Net Income | $-2,199,358 | $-1,591,470 | $-885,211 | $-260,623 | $-1,489,053 |
| Net Margin | -49.1% | -33.0% | -15.4% | -4.0% | -28.3% |
| EPS | $-0.72 | $-0.52 | $-0.29 | $-0.09 | $-0.49 |
Polydex Pharmaceuticals Limited, through its subsidiaries, develops, manufactures, and markets biotechnology-based products for the human pharmaceutical market worldwide. The company also manufactures bulk pharmaceutical intermediates for the veterinary pharmaceutical industry. It primarily offers dextran and derivative products, including iron dextran, a derivative of dextran that is injected into pigs at birth as a treatment for anemia; and dextran sulphate, a specialty chemical derivative of dextran used in biotechnology applications and the pharmaceutical industry. In addition, the company develops Ushercell, a high molecular weight cellulose sulphate for topical vaginal use primarily in the prevention and transmission of AIDS and other sexually transmitted diseases, as well as unplanned pregnancies. Further, it supplies ferric hydroxide and hydrogenated dextran solutions. The company sells its products through independent distributors and wholesalers, as well as directly to companies. The company was formerly known as Polydex Chemicals Limited and changed its name to Polydex Pharmaceuticals Limited in March 1984. Polydex Pharmaceuticals Limited was incorporated in 1979 and is based in Toronto, Canada.
Visit WebsiteEarnings History & Surprises
POLXFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2023 | Jun 15, 2023 | — | $-0.04 | — | — |
Q2 2023 | Jun 15, 2023 | — | $-0.04 | — | — |
Q4 2022 | Dec 15, 2022 | — | $-0.11 | — | — |
Q4 2022 | Dec 15, 2022 | — | $-0.11 | — | — |
Q3 2022 | Sep 15, 2022 | — | $-0.09 | — | — |
Q2 2022 | Jun 15, 2022 | — | $-0.02 | — | — |
Q4 2021 | Dec 15, 2021 | — | $-0.02 | — | — |
Q4 2021 | Dec 15, 2021 | — | $-0.02 | — | — |
Q3 2021 | Sep 15, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 15, 2021 | — | $-0.06 | — | — |
Q4 2020 | Dec 15, 2020 | — | $0.01 | — | — |
Q4 2020 | Dec 15, 2020 | — | $0.01 | — | — |
Q3 2020 | Sep 15, 2020 | — | $0.02 | — | — |
Q2 2020 | Jun 15, 2020 | — | $0.02 | — | — |
Q4 2019 | Dec 16, 2019 | — | $0.02 | — | — |
Q4 2019 | Dec 16, 2019 | — | $0.02 | — | — |
Q3 2019 | Sep 16, 2019 | — | $0.03 | — | — |
Q2 2019 | Jun 17, 2019 | — | $0.06 | — | — |
Q4 2018 | Dec 17, 2018 | — | $0.01 | — | — |
Q4 2018 | Dec 17, 2018 | — | $0.01 | — | — |
Latest News
Frequently Asked Questions about POLXF
What is POLXF's current stock price?
What is the analyst price target for POLXF?
What sector is Polydex Pharmaceuticals Limited in?
What is POLXF's market cap?
Does POLXF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to POLXF for comparison